Common Stock, Shares, Outstanding of Insight Molecular Diagnostics Inc. from 31 Dec 2015 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Insight Molecular Diagnostics Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2015 to 30 Sep 2025.
  • Insight Molecular Diagnostics Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 28,625,405, a 114% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Insight Molecular Diagnostics Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 28,625,405 +15,251,296 +114% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 28,617,046 +15,248,659 +114% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 28,599,285 +20,326,212 +246% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 17,452,824 +9,191,751 +111% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 13,374,109 +5,113,347 +62% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 13,368,387 +5,127,459 +62% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 8,273,073 -111,005,748 -93% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 8,261,073 +2,328,882 +39% 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 8,260,762 -110,358,059 -93% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 8,240,928 -110,367,893 -93% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 119,278,821 +27,032,217 +29% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 5,932,191 -86,299,726 -94% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 118,618,821 +26,461,001 +29% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 118,608,821 +28,292,513 +31% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 92,246,604 +3,332,604 +3.7% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 92,231,917 +23,115,115 +33% 31 Dec 2021 10-K 12 Apr 2023 2022 FY
Q3 2021 92,157,820 +24,906,820 +37% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 90,316,308 +23,098,308 +34% 30 Jun 2021 10-Q 11 Aug 2021 2021 Q2
Q1 2021 88,914,000 +26,430,000 +42% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 69,116,802 +12,084,802 +21% 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q3 2020 67,251,000 +15,278,000 +29% 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 67,218,000 +15,245,000 +29% 30 Jun 2020 10-Q 29 Jul 2020 2020 Q2
Q1 2020 62,484,000 +10,511,000 +20% 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 57,032,000 +16,368,000 +40% 31 Dec 2019 10-K 19 Mar 2021 2020 FY
Q3 2019 51,973,000 +11,309,000 +28% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 51,973,000 +12,565,000 +32% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 51,973,000 +14,155,236 +37% 31 Mar 2019 10-Q 14 May 2019 2019 Q1
Q4 2018 40,664,000 +9,212,000 +29% 31 Dec 2018 10-K 26 Mar 2020 2019 FY
Q3 2018 40,664,000 +9,247,000 +29% 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 39,408,000 +9,888,000 +33% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 37,817,764 +8,450,764 +29% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 31,452,000 +2,715,000 +9.4% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 31,417,000 +2,740,000 +9.6% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 29,520,000 +4,089,000 +16% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 29,367,000 +3,955,000 +16% 31 Mar 2017 10-Q 28 Apr 2017 2017 Q1
Q4 2016 28,737,000 +3,346,000 +13% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 28,677,000 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 25,431,000 30 Jun 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 25,412,000 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 25,391,000 31 Dec 2015 10-K 27 Feb 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.